Stock Movers
Stock Movers

Jun 19, 2026 · 7 min

US export concerns pressure ASML while weight loss prospects lift Novo Nordisk

ASML Down, Novo Rises, Nexans Gains

Understanding these market movements reveals how geopolitical tensions and healthcare innovations are actively shifting global capital.

3 key takeaways
  1. 1ASML faces market pressure amid concerns that its advanced chipmaking equipment ended up in China against US export rules.
  2. 2Novo Nordisk received a key stock upgrade from Nordea based on strong growth projections for its weight loss pill.
  3. 3European cable manufacturers Nexans and Prysmian gained momentum following strong financial results from Japanese rival Fujikura.

Don't miss

Chloe Melley explains how reports of ASML equipment ending up in China are fueling fears of tighter US export restrictions.

The brief

European markets are reacting to a mix of regulatory pressures and sector-specific momentum, led by chip equipment giant ASML facing scrutiny over potential US export violations regarding its shipments to China.

Meanwhile, pharmaceutical leader Novo Nordisk is seeing its stock rise following a key upgrade by Nordea, driven by optimistic projections for its weight loss pill pipeline.

In the industrial sector, European cable manufacturers Nexans and Prysmian are gaining ground after Japanese competitor Fujikura posted strong results, signaling robust global demand.

What was said on this episode

6 statements · 4 positive · 1 negative · 1 neutral

  1. Chloe Melleyon ASMLNeutral1:46

    ASML machines are large, scarce, and require constant employee upkeep.

    “they're the size of a school bus, they're made in very limited quantities and they also require a constant attention, constant upkeep from ASML employees”

    Listen at 1:46

  2. Chloe Melleyon ASMLNegative2:05

    ASML shares are weakening amid concerns about possible China export violations.

    “we are seeing ASML a little bit weak on the back of that this morning”

    Listen at 2:05

  3. Chloe Melleyon European obesity and diabetes research commercializationPositive3:39

    The research-incubator network aims to make Europe more competitive in obesity and diabetes research commercialization.

    “making Europe more competitive, more of a forward looking player in that space”

    Listen at 3:39

  4. Chloe Melleyon FujikuraPositive4:19

    Fujikura raised guidance after receiving more hyperscaler orders.

    “that company raised its guidance, said that they had seen a big boost in orders from hyperscalers”

    Listen at 4:19

  5. Chloe Melleyon European cable companiesPositive4:40

    European cable companies benefit from the data-center boom.

    “they're part of a sort of class of industrials that are providing, you know, one part of the other of, of that data center supply chain and really benefiting as a result from the boom”

    Listen at 4:40

  6. Prysmian shares have risen almost 80% this year.

    “Prismian is up almost 80% this year”

    Listen at 4:50

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Stock Movers

Stay updated on daily market-moving news and equity shifts across global exchanges

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

US export concerns pressure ASML while weight loss prospects lift Novo Nordisk | PodLume